Clinical Trials Sponsored by Telix International Pty Ltd

Total 33 results

Telix International Pty Ltd

Recruiting

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Soft Tissue Sarcoma | Cervical Cancer | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Glioblastoma Multiforme | Non Small Cell Lung Cancer | Cholangiocarcinoma | Epithelial Ovarian Cancer | Head and Neck Squamous Cell Carcinoma and other conditions

United States
Telix International Pty Ltd

Recruiting

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2)

Glioblastoma | Glioblastoma Multiforme | Neoplastic Disease

Australia, Austria, Netherlands, New Zealand
Telix International Pty Ltd

Completed

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC (ZIRDAC-JP)

Carcinoma, Renal Cell | Clear Cell Renal Cell Carcinoma

Japan
Telix International Pty Ltd

Completed

177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study (ProstACTSelect)

Metastatic Prostate Cancer

Australia
Telix International Pty Ltd

Completed

131I-IPA and Concurrent XRT in Recurrent GBM (IPAX-1)

Glioblastoma Multiforme

Austria, Australia, Netherlands
BAMF Health
Telix International Pty Ltd

Recruiting

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Metastatic Castration-resistant Prostate Cancer

United States
Telix International Pty Ltd
Grand Pharmaceutical (China) Co., Ltd.

Completed

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma (ZIRDOSE-CP)

Clear Cell Renal Cell Carcinoma | Recurrent Renal Cell Cancer | Suspected Recurrent Renal Clear Cell Carcinoma

China
Telix Pharmaceuticals (Innovations) Pty Ltd

Recruiting

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only (PROSTACT)

Metastatic Prostate Cancer

Australia, New Zealand
Radboud University Medical Center
ABX CRO; Telix International Pty Ltd

Completed

89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

Clear Cell Renal Carcinoma

Netherlands
Mayne Pharma International Pty Ltd

Completed

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Plaque Psoriasis

United States, Poland, Ukraine, Georgia
Mayne Pharma International Pty Ltd

Terminated

A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis

Lamellar Ichthyosis

United States, Spain, Canada, Germany, France, Australia, Israel, Ukraine, United Kingdom
Mayne Pharma International Pty Ltd

Completed

Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

Neutropenia

Australia
Mayne Pharma International Pty Ltd

Completed

Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg

Neutropenia

Australia
Telix Pharmaceuticals (Innovations) Pty Limited
Grand Pharmaceutical (China) Co., Ltd.

Recruiting

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Prostate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate Carcinoma

China
University of Texas Southwestern Medical Center
Telix International Pty Ltd; Once Upon a Time Foundation

Recruiting

PSMA PET Response Guided SabR in High Risk Pca

Prostate Adenocarcinoma

United States
Mayne Pharma International Pty Ltd
GlaxoSmithKline

Completed

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Psoriasis

United States
Mayne Pharma International Pty Ltd
GlaxoSmithKline

Completed

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Psoriasis

United States
BTG International Inc.
Iqvia Pty Ltd

Completed

A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy. (OASIS)

Breast Cancer

France
Tulane University
Mayne Pharma International Pty Ltd

Terminated

Combination Topical Therapy for Treatment of Scalp Actinic Keratoses

Actinic Keratoses

United States
Mayne Pharma International Pty Ltd
bioRASI, LLC

Completed

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

Head Lice

United States
Mayne Pharma International Pty Ltd
bioRASI, LLC

Completed

Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.

Scabies

United States
Odyssey Group International, Inc.
Avance Clinical Pty Ltd.

Recruiting

A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

Traumatic Brain Injury (TBI)

Australia
Johnson & Johnson International (Singapore) Pte...

Completed

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy (ACE)

High Risk Localized Prostate Cancer

Japan, Korea, Republic of, Taiwan
Kalbe International Pte. Ltd
Persahabatan Hospital

Recruiting

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Cancer, Lung | Malnutrition; Protein | Cancer Cervix

Indonesia
International Medical University
ThoughtFull World Pte. Ltd.

Completed

Assessing Effectiveness of ThoughtFullChat Application in Improving Mental Well-Being

Depression | Stress | Anxiety | Resilience

Malaysia
George R Thompson
Mayne Pharma International Pty Ltd

Withdrawn

SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole (SITRIS)

Coccidioidomycosis | Valley Fever

United States
Bharat Biotech International Limited
Indian Council of Medical Research; Iqvia Pty Ltd

Active, not recruiting

An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Covid19 | SARS-CoV Infection

India
ObsEva SA
Iqvia Pty Ltd; Cytel Inc.; Scope International AG; PhinC Development

Active, not recruiting

PoC Study of OBE022 in Threatened Preterm Labour (PROLONG)

Preterm Labor

Spain, Russian Federation, Vietnam, Czechia, Finland, Israel
Clover Biopharmaceuticals AUS Pty Ltd
International Vaccine Institute; Coalition for Epidemic Preparedness Innovations

Completed

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (SCB-2019)

COVID-19

Colombia, Belgium, Brazil, Philippines, South Africa
Bio-Scaffold International Pte Ltd
National University Hospital, Singapore; Saveetha University

Completed

Radiographic Assessment of Bone Regeneration in Alveolar Sockets With PLGA Scaffold

Preservation of Alveolar Bone Height With PLGA Bioscaffold

India, Singapore
The George Institute
Bayer; King Abdullah International Medical Research Center; George Clinical Pty... and other collaborators

Recruiting

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK)

Cardiovascular Disease | Chronic Kidney Diseases | Dialysis-dependent Kidney Failure

Taiwan, Australia, Malaysia, Tunisia, Singapore, Canada, France, India, Saudi Arabia
M. Eugenia Socias
Canadian Institutes of Health Research (CIHR); Mayne Pharma International Pty... and other collaborators

Terminated

Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder (pRESTO)

Opioid-Related Disorders | Opiate Substitution Treatment | Morphine | Fentanyl | Methadone

Canada
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Active, not recruiting

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

Chlamydia | Gonorrhea | Syphilis

United States

Clinical Trials Sponsored by Telix International Pty Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations